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Certain phenyl-substituted hyd ns of
environmental concen have the potential to
disrupt the endocrine system ofanimals,
apparently in association with their estro-
genic properties. Competition with natural
estrogens forthe estrogen receptorisaapossi-
ble mechanism by which such effects could
occur. We used comp molecular field
analysis (CoMFA), a three-dimensional
quantitative structure-activity relationship
(QSAR) paradigm, to examine the underly-
ing strict pprtes ofoP-corinate
hydroxybiphenyl analogs known to bind to
the estrogen receptor. The cross-validated
and conventional statistical results indicate a
high degree ofinternalpredictability forthe
molecules induded in the training data set
In addition to the phenolic (A) ring system,
conformational restriction of the overall
structure appears to play an important role
in estrogen receptor binding affinity.
Hydrophobic character as assessed using
hydropathic interaction fields also con-
tributes inapositivewayto bindingaffinity.
The CoMFA-derived QSARs may he usef
in examining the estrogenic a of a
wider range ofphenyl-substituted hy
bons of environmenal concern. Key word:
comparativemolecularfieldanalysis,estradi-
olequivalents, estrogen receptor, polychlori-
nated biphenyls, quantitative structure-
activity relationships. Environ Health
Perspec 103:702-707 (1995)
There is a growing concern (1,2) that a
number ofchemicals released into the envi-
ronment can disrupt the endocrine system
ofanimals, including humans. Among these
chemicals are the persistent, bioaccumula-
tive organochlorine compounds that
include some industrial chemicals such as
the polychlorinated biphenyls (PCBs). The
ability to mimic natural hormones such as
estradiol is one mechanism by which such
disruption could occur. Certain halogenat-
ed aromatic compounds have been shown
(3) to elicit estrogenic hormonal activity.
Mixtures ofPCBs were used as commercial
insulators due to their favorable dielectric
properties (4,5). However, these products
have been banned in the United States since
the 1970s (6X7). The highlychlorinated and
lipophilic nature of these compounds
underlie their persistence as environmental
contaminants, and they are known to cause
adverse reproductive effects in males (8)
and females (8, M.
Modified mixtures of PCBs, which are
lower in overall chlorine content yet rich in
ortho-chlorinated biphenyls, have been pro-
posed as alternatives to the highly chlori-
nated PCB mixtures. The lower chlorine
content favors increased metabolism in bio-
logical systems. Upon metabolic hydroxyla-
tion at vacant para positions, the more
highly ortho-chlorinated biphenyls can be
converted to possible metabolites capable of
binding to the estrogen receptor (10).
Bioaccumulation ofthese metabolites is not
expected to be a problem as long as the
enzymes responsible for conjugation and
elimination of such polar compounds are
not saturated and remain functional; how-
ever, continuous exposure to PCBs may
result in an overall increase in steady-state
concentrations ofthese metabolites (11).
In addition to the PCB family ofchemi-
cals, other phenyl-substituted hydrocarbons
such as the biphenyl ethanes and ethylenes
related to diethylstilbestrol (DES) (12) and
triphenylethanes (13), including tamoxifen
and nafoxidine, have been shown to be lig-
ands of the estrogen receptor. A common
substructure ofmany ofthese chemicals is a
phenolic ring system, with an obvious rela-
tionship to the phenolic A ring in estradiol
(Fig. 1). However, itis notclear ifin all cases
the hydroxyl group has unique properties as
asubstituent or ifanysimilar-sized (isosteric)
group, such as chlorine, could replace it.
Such a substructure serves as a unique way
to align the molecules for comparing the
overall structures of otherwise structurally
diverse chemicals. In this way it may be pos-
sible to determine their estradiol equivalency
(14) in a manner analogous to determining
the dioxin equivalency (15) of structurally
related chlorinated aromatichydrocarbons of
environmental health concern. We used
comparative molecular field analysis
(CoMFA) (16), a three-dimensional quan-
tiative structure-activity relationship
(QSAR) paradigm, to examine the unique
physicochemical properties ofpolychlorinat-
ed hydroxybiphenyls (Table 1) underlying
their estrogen receptor binding affinities and
thus theirpotential estradiol equivalency.
Methods
The SYBYL molecular modeling software
package (version 6.0, Tripos Associates,
Inc., St. Louis, Missouri) was used to do all
molecular modeling. The coordinates for
estradiol and DES were retrieved from the
Cambridge Structural Database. The
remaining molecules were constructed in
SYBYL using the sketch option. All mole-
cules were minimized using the standard
Tripos force field (17) to an energy change
convergence criterion of 0.001 kcal/mol.
The SYBYL geometries were used as start-
ing coordinates for full-geometry opti-
mization using MOPAC 5.0 (Quantum
Chemistry Program Exchange, Indiana
University, Bloomington, Indiana) with
theAMI (18) model Hamiltonian.
For each biphenyl molecule (including
DES), using the MOPAC/AMI optimized
structure as a starting point, the conforma-
tional space about the twist bond(s) con-
necting the two ring systems was explored.
This bond was systematically searched at
50 increments. The lowest energy con-
former obtained from the search was then
subjected to full MOPAC/AM1 optimiza-
tion. This structure was then aligned rela-
tive to estradiol by root-mean-squares
(RMS) fit of the hydroxyphenyl ring (A)
carbons and the corresponding carbons of
the para-substituted ring of the molecule
to be fitted. Due to structural symmetry of
the biphenyls, several alignments with
estradiol are possible. It was therefore nec-
essary to devise a logical process for the
selection of the "active conformation" to
be used in the analyses.
The procedure adopted may be summa-
rized as follows. First, all possible orienta-
tions (RMS-fitted superpositions with estra-
diol) of an individual molecule to be
aligned were saved as separate files. Each of
these molecules was then subjected to a
field-fit (template forcing) minimization
procedure using estradiol as the template.
Simply put, the field-fit algorithm forces a
test molecule to assume a conformation and
charge distribution similar as possible to
that of a template molecule at the expense
ofan increase in the internal potential ener-
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Figure 1. Comparison ofthe chemical structure of estradiol with a diethylstilbestrol derivative (top) and an
ortho-substituted biphenyl derivative (bottom). Green-colored atoms and bonds designate substructural
features ofestradiol which are similar, if notidentical, in size and shape tothe comparison molecules.
gy ofthe molecular system. Two additional
penalty terms are added to the Tripos mole-
cular mechanics force field equation to
achieve this: a steric field fit energy term
and a electrostatic field fit energy term. The
orientation of the test molecule displaying
the lowest energy penalty in order to mimic
the template molecule estradiol was then
optimized using full geometry and selected
as the "active" conformer in the "active"
alignment. This process is repeatable and
assures the selection of a low-energy con-
former most closely structurally related to
the template.
The bindingaffinities ofthe compounds
included in the training set are reported in
terms of the concentration (molar equiva-
lents, Meq) of competitor required to dis-
place 50% ofthe bound [3H]estradiol from
the estrogen receptor. The values for all
compounds were determined using uterine
cytosol from ovariectomized mice as report-
ed by Korach et al.(10). These values are
reported as the negative log of the concen-
tration necessary to displace 50% ofbound
[3H]estradiol from the estrogen receptor
and aredesignated as pC50.
The steric and electrostatic interaction
energies were calculated using an sp3
hybridized carbon probe atom with a
charge of +1.0 and a distance-dependent
dielectric function at all intersections of a
regularly-spaced (1.0A) grid ofdimensions
20 A x 17 A x 16 A. The cutoffvalue for
all interactions was set at ±30.0 kcal/mol.
Hydrophobicity field calculations were
performed according to the method of
Kellogg et al. (19) as employed in hydro-
pathic interaction (HINT). The hydro-
pathic interaction energies were deter-
mined at intersection points on the same
grid as used for the CoMFA interaction
energies. At each grid intersection point,
the net sum of the following empirical
equation was evaluated over all the atoms
for a given molecule:
At=Is.aii (1)
where sj = solvent accessible surface areafor
atom i;av= hydrophobic atom constant for
atom i; and Rit = er (r = distance between
atom iand test point t). These values were
imported into the QSAR molecular
spreadsheet (MSS) and treated as a single-
field (electrostatic) CoMFA-type column.
All statistical analyses were performed
usingthepartial-least-squares (PLS) method-
ology (20) as employed in the QSAR mod-
ule of SYBYL 6.0 running on Silicon
Graphics Indigo and Onyxworkstations. All
initial analyses were performed using the
leave-one-out (LOO) cross-validation (21)
technique and 10 principal components
(PCs). The cross-validated r2 (referred to as
q2 here) was computed as follows:
2 q = (SD - PRESS)/SD (2)
where SD is the sum ofthe squared devia-
tions between the measured and mean
binding affinities ofthe training set mole-
cules, and PRESS is the sum ofthe squared
deviations between the predicted and mea-
sured binding affinities for every molecule.
To increase the signal-to-noise ratio in
the CoMFA analyses, steric and electrostat-
ic columns with a standard deviation ofless
than 2.0 kcal/mol ("minimum aY") were
not included in the cross-validated analysis.
A minimum a of 0.5 kcal/mol was imple-
mented in the analyses using hydropathic
fields. The optimal number ofcomponents
to be used in thesubsequent non-cross-vali-
dated analysis was determined as that
which yielded the highest q2 value and the
lowest standard error ofcross-validated pre-
dictions (SEP) for training set molecules
determined during the LOO procedure.
For the non-cross-validated analyses, the
minimum a was reduced to 0.0 kcal/mol
(all columns were included in the analyses).
The results of all conventional and three-
dimensional QSAR analyses are summa-
rized inTable 2.
Results
Often the biological potency of highly
lipophilic molecules such as the phenyl-sub-
stitutedhydrocarbons is driven bytheirabil-
ity to cross biological membranes in vivo
(2Z) and, on a more pragmatic level, their
solubility in the assay medium in vitro. In
the absence ofdirect experimental data, the
conventional computational manner in
which partitioning/solubility is incorporated
into QSAR analyses is to estimate the
octanol:water partition coefficient using an
additive technique (23-25). Additive
approaches have proven to be inadequate
for estimating partition coefficients for posi-
tional isomers (26). To further illustrate the
limitations of the additive fragment (atom)
methods with respect to positional isomers,
the HINT-calculated logP (HINT logP)
value was used as a regressor. This resulted
in a cross-validated correlation coefficient
(q2) of-0.003 (s= 1.434) indicating that all
of the internal, cross-validated predictions
were outside the range ofthe standard devi-
ation ofthe data set. This analysis is useless.
The low statistical significance is also repre-
sented in a conventional correlation coeffi-
cient(r2) of0.221 (SEP = 1.264).
To overcome this phenomenon in the
analyses presented here, we used an empiri-
cally derived, three-dimensional field rep-
resenting the hydrophobicity of the mole-
cules. The use of these fields as determi-
nants ofthe hydropathic character ofmol-
ecules of this type has been validated in
analyses using structural isomers and
experimental RP-HPLC retention time, or
generator column, data (26). The analysis
based on HINT fields as the sole regressor
was less internally consistent yet more sta-
tistically robust than the unit-dimensional
HINT logP-based analysis (q2 = -0.302 2 using 1 PC with SEP = 1.634, r = 0.625
with s= 0.877).
Using this 14-molecule training set and
the CoMFA steric and electrostatic fields as
regressors, a cross-validated correlation
coefficient of 0.276 using 2 PCs with a
standard error of cross-validated predic-
tions (SEP) of 1.273 was generated. This
value indicates a low degree of internal
consistency, or predictability, for molecules
included in the training set. The non-
cross-validated analysis yielded a statistical-
ly robust correlation coefficient of 0.957
with a standard error of0.310. The model
based on the steric field alone was more
predictive (q2 = 0.345 using 2 PCs with a
Volume 103, Number 7-8, July-August 1995 703SEP of 1.211 with similar non-cross-vali- 1.614), yet statistically robust (r2 = 0.979; coefficient (q2 = 0.083 using 1 PC) with a
dated results (r = 0.960; s = 0.301). The s = 0.229). The combination of steric and decreased SEP (1.371). The non-cross-vali-
electrostatic field model was much less pre- hydropathic fields resulted in a compro- dated analysis yielded a correlation coeffi-
22 dictive (q = -0.058 using 3 PCs; SEP = mised model displaying a cross-validated cient (r ) of0.835 (s= 0.582).
Table 1. Physical properties ofcompounds inthe quantitative structure-activity relationship analysis (training set)
2-1-1'-2' PC50(Meq)
Nomenclature Compound/structure HINT log P Angle Actual Predicteda
OH
Estradiol H 4.87 NA 0.000 -0.059
OH
Diethylstilbestrol H ' O H 5.24 NA 0.398 0.415
2,4,6-Trichloro-4'-biphenylol HO CI 5.22 -90.1 -1.623 -1.666
cl
2,3,4,5-Tetrachloro-4'-biphenyloI HO C- 5.81 -60.4 -1.978 -2.076
Cl Ci
Cl
2-Chloro-4,4'-biphenyldiol HOOH 3.37 60.4 -1.954 -2.145
2,6-Dichloro-4'-biphenylol HO X 4.63 90.0 -2.589 -2.646
ci
2,5-Dichloro-4'-biphenylol HO 4.63 119.7 -2.704 -2.324
cl
3,4',5-Trichloro-4-biphenylol HO CI 5.22 40.1 -3.000 NA
3,3',5,5'-Tetrachloro-4,4'-biphenyldiol HOZ OH 5.14 40.3 -3.132 NA
Cl Cl
Cl
2-Chloro-4-biphenylol HO 4.04 59.9 -3.398 -3.415
4'-Chloro-4-biphenylol HO-C -C i 4.04 40.0 -3.591 -3.901
2,3,5,6-Tetrachloro-4,4'-biphenyldiol HO O H 3.33 -89.8 -3.699 NA
4,4'-Biphenyldiol HO-0 --OH 2.66 42.4 -4.000 -4.137
4-Biphenylol HO-~Q-~ 3.33 -57.6 -4.000 -3.484
Abbreviations: HINT, hydropathic interaction; NA, notapplicable.
8Predictions taken from non-cross-validated analysis ofsteric fieldthree-dimensional quantitative structure-activity relationship model without ionizable com-
pounds (8,9, and 12).
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Table 2. Summary of comparative molecular field analysis statistical results
Steric and Steric and
Hydropathic Steric Steric Electrostatic electrostatic hydropathic
Parameter logP field field field field fields fields
-0.003(1) -0.302(1) 0.345(2) 0.544(2) -0.058(3) 0.276(2) 0.083(1)
SEP 1.434 1.634 1.211 1.124 1.614 1.273 1.317
r? 0.221 0.625 0.960 0.974 0.979 0.957 0.835
s 1.264 0.877 0.301 0.270 0.229 0.310 0.582
F 3.405 19.983 130.526 148.464 152.528 122.319 60.688
p 0.090 0.001 0.000 0.000 0.000 0.000 0.000
Relative field contributions
Steric NA 100% 100% NA 55% 65%
Electrostatic NA NA NA 100% 45% NA
Hydropathic 100% NA NA NA NA 35%
Abbreviations: SEP, standard error of cross-validated predictions; NA, not applicable. aThree dimensional quantitative structure-activity relationship model without ionizable compounds (8,9,
and 12).
bNumber of principal components in parentheses.
Three PCB derivatives (8, 9, and 12) in
the training set possess chlorine sub-
stituents adjacent to the para-hydroxyl
group. The plA of the hydroxyl group in
these compounds is calculated by manufac-
turer (CompuDrug Chemistry Ltd,
Budapest) to be lower (6.7, 6.2, and 5.8,
respectively) than the pH ofthe assay medi-
um (7.6). Therefore, it is expected that
these compounds would be ionized and
behave much differently from the remain-
ing nonionized compounds expressing
much higher p)A values (greater than 9.0 in
all cases). A subsequent analysis using only
steric fields as regressors and the remaining
11 compounds as observations yielded a
much more predictive (q2 = 0.544 using 2
2 PCs) and robust (r = 0.974) model.
To demonstrate the utility of this
three-dimensional QSAR model, the estro-
gen receptor binding affinities of several




(PCB153)] were predicted using the 11-
compound model described above. To our
knowledge, these three PCBs have not
been screened for the estrogen receptor
binding affinity. Our predictions illustrate
the importance of conformational restric-
tion about the twist bond. PCB77, the
least conformationally restricted ofthe test
set, was predicted to have a binding affini-
ty (predicted pC50) of -2.447. The ortho-
substituted (conformationally restricted)
and non-para -substituted PCB52 was pre-
dicted to be a weaker binder (predicted
pC50 = -3.104). The putative biologically
active (estrogenic) metabolite of PCB52,
2,2',5,5'-tetrachloro-4-biphenylol, was
predicted to be slightly more potent than
the parent (pC50 = -3.011). The conforma-
tionally restricted and para-substituted
analog PCB153 was predicted to be much
more potent than PCB52 with a predicted
pC50 value of-2.613.
Discussion
Results from in vivo uterine weight assays
indicate that the ortho-substituted PCB52
acts as an estrogenic compound (24. This
activity may be manifest through a putative
hydroxylated metabolite binding competi-
tively to the estrogen receptor. PCB77, a
dioxinlike coplanar biphenyl, was discov-
ered to produce antiestrogenic responses
(27). In this case, the antiestrogenicity may
be mediated by induction of estrogen
metabolizing enzymes (28), through down-
regulation of estrogen receptors (29), or
decreased affinity of the ligand:receptor
complex for the DNA estrogen response
element (30), rather than competitive inhi-
bition at the estrogen receptor. This non-
ortho-substituted PCB was modeled in the
non-coplanar conformation which possibly
accounts for the relatively "active" predict-
ed value. The low-energy barrier to rotation
about the twist bond assures the existence
ofthe coplanar conformation ofthis mole-
cule in vivo. As such, this molecule is a
competitive ligand for the Ah (dioxin)
receptor, and it is therefore suggested that
the predicted estrogen receptor affinity is
an overestimate and not truly reflective of
actual estrogenic or antiestrogenic potency
ofthe compound.
The low binding affinity prediction for
PCB52, the conformationally restricted yet
non-para-substituted test set molecule, is
presumably due to the lack of a para-sub-
stituent. The increase in the predicted
affinity value for the para-hydroxylated
derivative (2,2,', ,5'-tetrachloro-4-
biphenylol) supports this conclusion. It is
important to note that none ofthe training
set molecules possesses a single chlorine
substituent adjacent to the hydroxyl moiety
ofthe phenol ring. This may have implica-
tions regarding the predictive power ofthe
model with respect to compounds exhibit-
ing this substitution pattern. It has, howev-
er, been shown that halogenation of the
phenolic (A) ring ofestradiol in the corre-
Figure Z. PCLB analogs included in test set. lop:
PCB77; middle: PCB52; bottom: PCB153.
sponding positions (2 or 4 substituted)
does not diminish, and in certain cases
enhances, the estrogen receptor binding
ability ofthe ligand (31). In summary, the
model suggests that biphenyls possessing
both ortho- and para-substituents, charac-
teristics ofenvironmentally persistent PCB
residues, may be competitive ligands ofthe
estrogen receptor.
The model confirms the use of the
phenolic (A) ring alignment in comparing
various potential estrogen receptor ligands
of environmental origin. This approach
could be particularly useful when applied
to additional hydroxylated and halogenat-
ed metabolites or transformation products
of certain phenyl-substituted chemicals of
environmental concern (32). As previously
reported (33) and supported here, the phe-
nolic ring moiety is not a necessary
requirement for estrogen receptor affinity.
Further binding studies, ideally on the
nonhydroxylated PCBs predicted in this
report, are needed to assess the unique role
and contribution of the hydroxyl group.
Additionally, work is needed to assess the
role and importance of solubility in the
assay medium and molecular hydrophobic
properties in estrogenic activity of such
chemicals, especially in comparing in vitro
and in vivo results. In some cases the in
vitro binding results may be complicated
bydesolvation energy differences associated
with the hydroxyl group and its hydrogen
bonding properties (34). If the hydroxyl
group is shown not to be a unique require-
ment in such structures, it may be possible
to extend this approach to a more struc-
turally diverse range of conformationally
restricted phenyl-substituted chemicals,
such as the chlorinated diphenylethers.
It is also important to acknowledge
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that the available training data set is heavi-
ly weighted toward unsymmetrical chlori-
nation patterns. The environmental/bio-
logical relevance of several of these com-
pounds is questionable (35,36). In the final
model, only two compounds (5 and 10)
possessed a chlorine substituent on the
phenolic ring. Studies are currently under-
way in our laboratory to explore the effects
of substitution patterns on the phenolic
ring. Special emphasis is being placed on
the effects of chlorine adjacent to the
hydroxy group. The more highly chlorinat-
ed compounds ofthis type are biologically
persistent due to increased fat solubility
(relative to congeners possessing fewer
chlorines) and possibly resistance to meta-
bolic transformations (e.g., glucoronide
conjugation) due to steric blocking (11).
While the approach presented here is a
useful tool for predicting the estrogen
receptor binding affinity ofunknown com-
pounds, it does have a caveat in the form of
the limited availability ofcompatible bind-
ing assay data. Further refinement of the
model will continue as the data become
available. Ultimately, it is anticipated that
the model will assume one of two forms.
Using binding data ofthe form used in the
development of the model (C50 values for
displacement ofestradiol from the estrogen
receptor) coupled with data indicating
whether the given ligand induces either
estrogenic or antiestrogenic effects in vitro
or in vivo, the model could be logically
divided into two models. One model
would be constructed for estrogenic com-
pounds (agonists), another for compounds
that demonstrate antiestrogenic responses
through competitive antagonism at the
estrogen receptor. Clearly, the existence of
mixed agonists/antagonists must be consid-
ered in these refined models. It is possible
to include compounds displaying this phar-
macological profile in both, or neither,
models. The underlying hypothesis is that
mixed agonists/antagonists possess structur-
al features distinct from or common to the
pure agonists/antagonists structures which
would be identified and quantified by the
CoMFA QSAR model. The results ofthese
models, in the form of the three-dimen-
sional CoMFA contour plots, would be
compared to highlight structural differences
of the binding domain of the receptor
which are induced upon complexation with
estrogenic and antiestrogenic compounds.
These results will be used in conjunction
with protein homology modeling studies to
aid in the refinement and validation of
models ofthe hormone binding domain of
the estrogen receptor (37).
In conclusion, PCBs and related com-
pounds are ubiquitous environmental cont-
aminants. Traditionally, the most signifi-
cant toxicological action of members of
these classes ofcompounds has been attrib-
uted to their resistance to metabolic degra-
dation and their ability to achieve coplanar
conformations. The present study suggests
that the non-coplanar PCBs and related
compounds should be considered as poten-
tial environmental toxicants due to their
interaction with hormone receptors. Non-
coplanarity, manifest through ortho-substi-
tution, increases the steroidlike (more rigid)
structural nature of the PCBs, contributes
to the overall hydrophobic bulk structure,
and possibly serves to inhibit any competi-
tive coplanar-type binding activity (dioxin-
like). The technique described here has been
proven to be a useful tool for the prediction
of the estrogen receptor binding affinities
for a variety ofstructurally related chemical
compounds. Currently underway in our
laboratory is the development ofa CoMFA
model including less structurally related
molecules. It is anticipated that models of
this type may provide the foundation for
the description of the toxicological activity
of ostensibly structurally diverse, phenyl-
substituted hydrocarbons of environmental
concern in terms ofestradiol equivalents.
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Society of Toxicology
Reproductive and Developmental Toxicology Subsection
Graduate/Postdoctoral StudentAward
We announce our intention to make awards of recognition for the best platform
and/or poster presentation by graduate students or postdoctoral fellows in the
areas of reproductive and developmental toxicology at the 1996 Annual Meeting of
the Society of Toxicology, which will be held in Anaheim, California on March 10-14.
General areas of research can include female or male reproductive toxicology, repro-
ductive endocrine toxicology, teratology/developmental toxicology, and/or postnatal
functional assessment. Candidates for these awards should send to the address
listed below, by November 1, 1995, a copy of the abstract that is being submitted to
the Society for this meeting. An outline of the talk or a copy of the poster material
should also be included if possible, to assist thejudges.
The abstracts and posters should describe original research which may include
applied studies, investigations of mechanisms of toxic response, or studies of basic
biochemical, physiologic, or genetic mechanisms of action. Interested individuals may
request Society information and abstract forms from the address below. All sub-
mitted material will be treated as confidential. The winning presentations will be
announced at the Annual Meeting of the Specialty Subsection in Anaheim. For fur-
ther information, please contact:
Robert J. Kavlock, Ph.D.
U.5. Environmental Frotection Agency
Health Effects Research Laboratory
Developmental Toxicology Division (MD-71)
Research Triangle rark, NC 27711
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